Saúde Pública/Medicina Humanitária

Cuidado a idosos durante a pandemia de COVID-19.

15 Mar, 2022 | 13:18h

Caring for older adults during the COVID-19 pandemic – Clinical Microbiology and Infection

Prevalência global, regional e nacional e fatores de risco para doença pulmonar obstrutiva crônica.

15 Mar, 2022 | 13:14h

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis – The Lancet Respiratory Medicine

Comentário no Twitter

NEW Research—LMICs account for more than 3/4 of global #COPD cases. W/ increased life expectancy in the majority of LMICs, prevalence of COPD in these countries is set to increase.

Study from NIHR @RESPIREGlobal Respiratory Health Unit https://t.co/KD1OSHuMAr pic.twitter.com/Mfm1uJ2tBm

— The Lancet Respiratory Medicine (@LancetRespirMed) March 11, 2022

“Suprimimos nossa imaginação científica”: 4 especialistas examinam os grandes sucessos e fracassos da resposta à COVID até agora.

15 Mar, 2022 | 13:13h

‘We suppressed our scientific imagination’: four experts examine the big successes and failures of the COVID response so far – The Conversation

Estudo randomizado de centro único | Cuidado da hepatite C acessível a usuários de drogas injetáveis.

15 Mar, 2022 | 13:07h

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial – JAMA Internal Medicine (gratuito por tempo limitado)

Comentário no Twitter

This randomized clinical trial found that the accessible care model provides a framework for developing treatment programs geared toward engaging, treating, and curing hepatitis C virus infection in people who inject drugs. https://t.co/zauS1gtPgO

— JAMA Internal Medicine (@JAMAInternalMed) March 14, 2022

Revisão sistemática | Efetividade do rastreamento de contatos no controle de doenças infecciosas.

14 Mar, 2022 | 14:06h

Effectiveness of contact tracing in the control of infectious diseases: a systematic review – The Lancet Public Health

Revisão sistemática e metarregressão | Duração da efetividade das vacinas contra infecção por SARS-CoV-2 e COVID-19.

14 Mar, 2022 | 14:05h

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression – The Lancet

Comentários:

Review of pre-Omicron data finds COVID-19 vaccine protection from severe disease remains strong at six months – Johns Hopkins University Bloomberg School of Public Health

Waning of COVID-19 vaccine effectiveness: individual and public health risk – The Lancet

Conteúdos relacionados: [Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although it did decrease some (on average, 8-10 percentage points) between one and six months after full vaccination”.

Como parar as pandemias antes que elas comecem: lições aprendidas com o SARS-CoV-2.

14 Mar, 2022 | 14:03h

Stopping pandemics before they start: Lessons learned from SARS-CoV-2 – Science

A epidemiologia em modificação do SARS-CoV-2.

14 Mar, 2022 | 14:02h

The changing epidemiology of SARS-CoV-2 – Science

Revisão sistemática | Testes rápidos de carga viral para detectar alta carga viral de HIV em pessoas que vivem com HIV/AIDS em instituições de saúde.

14 Mar, 2022 | 13:48h

Point‐of‐care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities – Cochrane Library

Resumo: Point-of-care tests for detecting high viral load in people living with HIV attending healthcare facilities – Cochrane Library

Diretriz OMS | Uso de testes diagnósticos rápidos de detecção de antígeno do SARS-CoV-2 para o autoteste de COVID-19.

11 Mar, 2022 | 15:18h

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing – World Health Organization